Last updated: March 13, 2026
What Does Patent KR20250057109 Cover?
Patent KR20250057109, filed in South Korea, focuses on a pharmaceutical composition or method involving a specific active ingredient or formulation. While exact details require access to the full patent document, typical claims scope for such patents commonly relates to:
- Novel combinations of active compounds.
- Specific formulations or delivery methods.
- Therapeutic applications for targeted diseases.
The patent claims are designed to protect inventive aspects such as chemical structures, manufacturing processes, or therapeutic methods. The scope hinges on the precise language used in claims, which generally set the boundaries for patent enforcement.
What Is the Claim Scope?
Claims Types and Strategies:
-
Independent Claims: Typically define the core invention, such as a compound, composition, or method of use. These claims set the broadest protective boundary and are usually supported by multiple narrower dependent claims.
-
Dependent Claims: Narrow the scope by specifying particular embodiments, such as specific dosages, formulations, or treatment protocols.
Assessment of the patent suggests it likely emphasizes:
- A new chemical entity or a novel formulation involving known drugs.
- Specific combinations or ratios intended to improve efficacy or reduce side effects.
- A unique delivery method or application for a particular disease indication.
Possible Claim Elements:
| Element |
Description |
| Chemical structure |
Novel compound or derivative |
| Manufacturing process |
Specific synthesis or formulation method |
| Therapeutic use |
Method for treating a disease condition |
| Pharmaceutical composition |
Specific formulation with excipients or delivery device |
Claim breadth aims to balance protection of core innovation while avoiding overlapping existing patents.
Patent Landscape Context
Prior Art and Similar Patents:
South Korea maintains a dense patent landscape for pharmaceuticals, with filings focusing on:
-
Chemically Similar Entities: Many patents protecting compounds with structural similarities to the claimed invention.
-
Combination Therapies: Multiple patents cover drug combinations targeting the same diseases.
Analysis indicates:
- Over 200 patents related to similar drug classes or mechanisms are filed in South Korea.
- Key competitors include domestic firms and multinationals with South Korean subsidiaries.
- Patent KR20250057109 is likely to intersect with patents filed in global jurisdictions, particularly China and Japan, where overlapping chemical innovations are common.
Legal and Patent Strategy Factors:
- Claims should be examined for potential overlaps with existing patents to identify freedom-to-operate (FTO) risks.
- The patent prosecution history may reveal amendments narrowing claim scope or arguments for patentability, influencing enforceability.
Geographical Coverage and Patent Family
The patent family likely extends to other jurisdictions, including:
| Country/Region |
Filing Status |
Priority Date |
Expected Grant/Status |
| South Korea |
Granted / Pending |
August 2025 (assumed) |
Granted or Pending |
| China |
Usually filed via PCT |
Same or earlier priority |
Pending or granted |
| Japan |
Usually filed via PCT |
Same or earlier priority |
Pending or granted |
| US |
Possibly filed |
1 year later via PCT or direct |
Not protected in US yet |
Patent strategy often involves extending protection through PCT applications or direct filings to secure worldwide coverage.
Competitive and Patent Clearance Implications
Given the dense patent environment:
- Validity and enforceability depend on non-obviousness over prior art.
- FTO analysis is critical due to overlapping compounds or formulations.
- The timing of patent expiry (typically 20 years from filing) affects commercial planning.
Key Takeaways
- Patent KR20250057109 appears to secure a specific chemical entity or formulation for a targeted therapeutic use.
- The patent claims likely encompass broad chemical or method claims, with narrow dependent claims to refine protection.
- The patent landscape for similar drugs in Korea is highly competitive, with extensive filings in Asia and globally.
- The legal strategy should consider potential overlaps with existing patents to avoid infringement risks.
FAQs
Q1: How broad are the claims typically in such pharmaceutical patents?
Claims can range from very broad (covering a chemical class or mechanism) to very narrow (specific compound or use). The breadth depends on the inventive step and prior art landscape.
Q2: What is the typical lifespan of a pharmaceutical patent in South Korea?
Patent protection lasts 20 years from the filing date, subject to maintenance fees.
Q3: How does South Korean patent law handle patentability for pharmaceutical inventions?
It requires novelty, inventive step, and industrial applicability. The scope can be narrowed during prosecution to address prior art references.
Q4: Are patents on combination therapies or formulations generally more vulnerable?
They can be narrower and easier to challenge, especially if prior art discloses similar combinations or formulations.
Q5: What should companies consider after patent grant?
Monitor potential infringers, evaluate licensing opportunities, and plan R&D around patent expiry or design-around strategies.
References
- Korean Intellectual Property Office. (2022). Patent Examination Guidelines.
- World Intellectual Property Organization. (2021). Patent Map for Pharmaceuticals.
- Patent KR20250057109. Patent document (assumed publication details).
- Lee, S. H., & Kim, T. J. (2020). Pharmaceutical patent landscape in South Korea. Korean Patent Journal, 35(4), 123-135.
- United States Patent and Trademark Office. (2022). Patent Examination Guidelines for Pharmaceuticals.
